AGITATION
Clinical trials for AGITATION explained in plain language.
Never miss a new study
Get alerted when new AGITATION trials appear
Sign up with your email to follow new studies for AGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug calms dementia agitation in major trial
Symptom relief CompletedThis study tested a medicine called BXCL501 for calming sudden episodes of agitation in people with dementia. 151 participants took the medicine as needed over 12 weeks. The goal was to see if it safely reduces symptoms like tension and hostility.
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 17, 2026 02:46 UTC
-
Can a sedative drug shorten ICU delirium?
Symptom relief CompletedThis study tested whether a drug called dexmedetomidine can reduce how long ICU patients feel agitated and confused (delirium). The study included 168 adults in the ICU who were not on breathing machines. Researchers measured how long agitation and delirium lasted, and whether pa…
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Hope for Alzheimer's agitation: new drug shows promise in major trial
Symptom relief CompletedThis study tested an experimental drug called AXS-05 to see if it can safely reduce agitation in people with Alzheimer's disease. Agitation includes restlessness, aggression, and emotional distress. The trial involved 408 participants and compared the drug to a placebo (a dummy p…
Matched conditions: AGITATION
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 04, 2026 16:17 UTC